Omnimmune Holdings, Inc.
OMMH · OTC
12/31/2009 | 12/31/2008 | 5/31/2008 | 5/31/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 100% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,522 | $5,476 | $48 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,522 | $5,476 | $48 | $9 |
| Operating Income | -$1,522 | -$5,476 | -$48 | -$9 |
| % Margin | – | – | -10,698.7% | – |
| Other Income/Exp. Net | $1,522 | -$514 | $48 | $9 |
| Pre-Tax Income | $0 | -$5,990 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,761 | -$5,990 | -$48 | -$9 |
| % Margin | – | – | -10,698.7% | – |
| EPS | -0.2 | -1 | -0.01 | -0.001 |
| % Growth | 80% | -9,900% | -1,150% | – |
| EPS Diluted | -0.2 | -1 | -0.01 | -0.001 |
| Weighted Avg Shares Out | 8,844 | 6,014 | 3,202 | 10,511 |
| Weighted Avg Shares Out Dil | 8,844 | 6,014 | 3,202 | 10,511 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $239 | $7,044 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1,522 | -$5,476 | -$48 | -$9 |
| % Margin | – | – | -10,698.7% | – |